Efficacy of phentermine/topiramate extended release in weight management and metabolic profiles: A multicentre study in South Korea
Diabetes, Obesity and Metabolism · 2025
DOI: 10.1111/dom.16342 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Diabetes, Obesity and Metabolism, 2025. Verfasst von Kyoung Min Kim und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Internal Medicine, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, South Korea. Hauptthemen laut MEDLINE: Topiramate, Phentermine, Obesity, Anti-Obesity Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Research Supporting Program CKD pharmaceutical company, Seoul, South Korea.
Abstract (Originalsprache)
Aims
Clinical trials have demonstrated the effectiveness of the phentermine and topiramate combination in weight management. This research evaluated the efficacy and safety of phentermine/topiramate extended release (ER) for weight management, focusing on alterations in body weight and metabolic parameters in routine clinical practice. Materials and Methods We retrospectively included people with obesity who initiated phentermine/topiramate ER between January 2020 and April 2023 at 10 tertiary hospitals in South Korea. The study assessed body weight changes at 5–6 months and for those who continued, at 12 months, along with metabolic parameters. Total body weight was measured using calibrated electronic scales with participants in light indoor clothing.
Results
The cohort included 1839 patients (540 men and 1299 women), with a 5–6‐month continuation rate of 48%. At 5–6 months, the mean weight reduction was 7.9%, with sex‐specific losses of 7.1% in men and 8.2% in women. Over 56% of participants achieved more than 5% weight loss, with 23% exceeding a 10% reduction. Younger participants, women and those with moderate to severe obesity exhibited more pronounced weight loss compared to older men and individuals with mild obesity, respectively. Concurrently, phentermine/topiramate ER treatment improved glucose regulation, lipid profiles and decreased blood pressure: the HbA1c decreased by 0.4 ± 0.9%, low‐density lipoprotein (LDL) cholesterol by 10 ± 32 mg/dL and systolic blood pressure by 6 ± 15 mmHg (all p < 0.001). Treatment was well‐tolerated, with a 15% incidence of mild adverse events like paresthesia, dry mouth and insomnia. At 12 months, patients who persisted in treatment (21%) experienced an average weight loss of 9.6%, with 65% surpassing a 5% weight loss.
Conclusion
The study suggests phentermine/topiramate ER is an effective option for obesity management in a South Korean population, though long‐term adherence remains a challenge.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, Internal Medicine, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, South Korea.
- Division of Endocrinology and Metabolism, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, South Korea.
- Department of Family Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, South Korea.
- Deptartment of Family Medicine, CHA Bundang Medical Center, CHA University, Seongnam, South Korea.
- Department of Internal Medicine, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
- Department of Family Medicine, Korea University Guro Hospital Korea University College of Medicine, Seoul, South Korea.
ORCID-Profile: Kyoung Min Kim, Ga Eun Nam, Soo Lim
Förderung
- Research Supporting Program CKD pharmaceutical company, Seoul, South Korea
Zitieren
APA
Kim, K. M., Choi, J. H., Han, B., Hur, Y. I., Son, J. W., Nam, G. E., Kang, J. H., Cho, Y. J., Kim, W. J., & Lim, S. (2025). Efficacy of phentermine/topiramate extended release in weight management and metabolic profiles: A multicentre study in South Korea. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.16342
Vancouver
Kim KM, Choi JH, Han B, Hur YI, Son JW, Nam GE, et al. Efficacy of phentermine/topiramate extended release in weight management and metabolic profiles: A multicentre study in South Korea. Diabetes, Obesity and Metabolism. 2025. doi:10.1111/dom.16342
BibTeX
@article{Kim2025,
author = {Kim, Kyoung Min and Choi, Jong Han and Han, Byoungduck and Hur, Yang-Im and Son, Jang Won and Nam, Ga Eun and Kang, Jee-Hyun and Cho, Yoon Jeong and Kim, Won Jun and Lim, Soo},
title = {Efficacy of phentermine/topiramate extended release in weight management and metabolic profiles: A multicentre study in South Korea},
journal = {Diabetes, Obesity and Metabolism},
year = {2025},
doi = {10.1111/dom.16342}
}
EUVIMED